MedPath

Comparison of Workplace Obesity Management Programs

Not Applicable
Completed
Conditions
Obesity
Cardiovascular Diseases
Heart Diseases
Interventions
Behavioral: Diet
Behavioral: Exercise
Behavioral: Environmental Obesity Program - Healthy Culture
Registration Number
NCT00122928
Lead Sponsor
Emory University
Brief Summary

The purpose of this study is to design and demonstrate the feasibility of implementing moderate and intensive environmental obesity prevention programs at major worksites.

Detailed Description

BACKGROUND:

More than half of all Americans are overweight or obese, and the prevalence of these risk factors has increased dramatically in the past decade. Obesity is a risk factor for several chronic illnesses, including type 2 diabetes and heart disease. The national medical cost that is attributed to obesity is estimated to be between $60 and $93 billion. Business leaders are becoming increasingly aware of the human and economic burden that poor health imposes on their workers. Many employers have invested in health promotion and disease prevention programs aimed at reducing the prevalence of obesity in the workplace through the encouragement of physical activity, maintaining a healthy diet, and improved management of health risk factors. Employers continue to seek innovative and evidence-based programs that can be implemented in the workplace to address a growing public health epidemic that also adversely affects worker productivity.

DESIGN NARRATIVE:

The primary objective of this study will be to evaluate the effect of introducing two levels of environmental programs, in addition to existing individualized programs, at reducing obesity in the workplace. Five outcomes will be evaluated: 1) body mass index and other weight-related biometric measures; 2) behavioral health risk factors; 3) weight-related health conditions; 4) health care utilization and medical expenditures; and 5) employee productivity measured in terms of reduced absenteeism and on-the-job presenteeism. The study will also include an assessment of costs and benefits of the two programs, including the medical, absenteeism, and productivity benefits, and an assessment of the impact of the programs on the worksite climate. Twelve Dow chemical companies will participate in the study. Participants will be randomly assigned to a moderate environmental program, an intensive environmental program, or a control group, which will receive individualized treatment only. The moderate program will include inexpensive environmental changes (e.g., prompts and reminders). In the high intensity program, senior managers will assist in the development of a worksite culture that is broadly supportive of improved weight and health management by employees. Annual health screening and biometrics data along with administrative medical claims, absence records, and productivity survey data will be analyzed to determine program impacts. Non-experimental statistical methods will be used to control the differences that remain across sites after randomization. The study will also produce extensive information about how employers can successfully implement environmental programs to reduce obesity at worksites.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5124
Inclusion Criteria
  • Active employees at any of 12 participating company locations of The Dow Chemical Company
  • Participants must be must be between 18 and 70 years old
Exclusion Criteria
  • The Dow Chemical Company employees located at a facility other than one of the 12 study sites

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High intensity environmental interventionDietIntense intervention
High intensity environmental interventionExerciseIntense intervention
High intensity environmental interventionEnvironmental Obesity Program - Healthy CultureIntense intervention
Moderate intensity environmental interventionDietModerate intervention
Moderate intensity environmental interventionExerciseModerate intervention
Primary Outcome Measures
NameTimeMethod
Prevalence of obesityMeasured at baseline and at the end of years 1 and 2
Weight-related risk factorsMeasured at baseline and at the end of years 1 and 2
Overall health and well-beingMeasured at baseline and at the end of years 1 and 2
Healthcare utilization and expendituresMeasured at baseline and at the end of years 1 and 2
Employee productivity measures (i.e., absenteeism and presenteeism)Measured at baseline and at the end of years 1 and 2
Return on investment (measured at Year 2)Measured at baseline and at the end of years 1 and 2
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath